NASDAQ
MRUS

Merus BV

PHARMACEUTICAL PREPARATIONS
LIFE SCIENCES

Prices are adjusted according to historical splits.

Merus BV Stock Price

Vitals

Today's Low:
$19.6100
Today's High:
$21.2600
Open Price:
$20.5300
52W Low:
$13.46
52W High:
$33.09
Prev. Close:
$20.5000
Volume:
149257

Company Statistics

Market Cap.:
$0.918 billion
Book Value:
7.12
Revenue TTM:
$0.053 billion
Operating Margin TTM:
-196.5%
Gross Profit TTM:
$-0.049 billion
Gross Profit TTM:
$-0.049 billion
Profit Margin:
-102.2%
Return on Assets TTM:
-15.7%
Return on Equity TTM:
-19.8%

Company Profile

Merus BV had its IPO on 2016-05-19 under the ticker symbol MRUS.

The company operates in the LIFE SCIENCES sector and PHARMACEUTICAL PREPARATIONS industry. Merus BV has a staff strength of 0 employees.

Stock update

Shares of Merus BV opened at $20.53 at the start of the last trading session i.e. 2022-11-02.

The stocks traded within a range of $19.61 - $21.26, and closed at $20.38.

This is a -0.59% slip from the previous day's closing price.

A total volume of 149,257 shares were traded at the close of the day’s session.

In the last one week, shares of Merus BV have slipped by -15.08%.

Merus BV's Key Ratios

Merus BV has a market cap of $0.918 billion, indicating a price to book ratio of 2.993 and a price to sales ratio of 17.41.

In the last 12-months Merus BV’s revenue was $0.053 billion with a gross profit of $-0.049 billion and an EBITDA of $-0.102 billion. The EBITDA ratio measures Merus BV's overall financial performance and is widely used to measure its profitability.

In the trailing 12-month period, Merus BV’s operating margin was -196.5% while its return on assets stood at -15.7% with a return of equity of -19.8%.

In Q2, Merus BV’s quarterly earnings growth was a positive 0% while revenue growth was a positive 2.5%.

Merus BV’s PE and PEG Ratio

Forward PE
-
Trailing PE
-
PEG
0

Its diluted EPS in the last 12-months stands at $-1.867 per share while it has a forward price to earnings multiple of - and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.

The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Merus BV’s profitability.

Merus BV stock is trading at a EV to sales ratio of 11.67 and a EV to EBITDA ratio of -6.02. Its price to sales ratio in the trailing 12-months stood at 17.41.

Merus BV stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.

Balance sheet and cash flow metrics

Total Assets
$0.000 billion
Total Liabilities
$0.000 billion
Operating Cash Flow
$0.000 billion
Capital Expenditure
$0.000 billion
Dividend Payout Ratio
0%

Merus BV ended 1970 with $0.000 billion in total assets and $131.2 billion in total liabilities. Its intangible assets were valued at $0.000 billion while shareholder equity stood at $0.000 billion.

Merus BV ended 1970 with $0.000 billion in deferred long-term liabilities, $0.000 billion in other current liabilities, billion in common stock, $0.000 billion in retained earnings and $0.000 billion in goodwill. Its cash balance stood at $0.000 billion and cash and short-term investments were $0.000 billion. The company’s total short-term debt was $0.000 billion while long-term debt stood at $0.000 billion.

Merus BV’s total current assets stands at $0.000 billion while long-term investments were $0.000 billion and short-term investments were $0.000 million. Its net receivables were $0.000 billion compared to accounts payable of $0.000 billion and inventory worth $0.000 billion.

In 1970, Merus BV's operating cash flow was $0.000 billion while its capital expenditure stood at $0.000 billion.

Comparatively, Merus BV paid $0 billion in dividends in 1970.

Other key metrics

Current Trading Price
$20.38
52-Week High
$33.09
52-Week Low
$13.46
Analyst Target Price
$42.3

Merus BV stock is currently trading at $20.38 per share. It touched a 52-week high of $33.09 and a 52-week low of $33.09. Analysts tracking the stock have a 12-month average target price of $42.3.

Its 50-day moving average was $0 and 200-day moving average was $0 The short ratio stood at indicating a short percent outstanding of 0%.

Around 0% of the company’s stock are held by insiders while 0% are held by institutions.

Frequently Asked Questions About Merus BV

The stock symbol (also called stock or share ticker) of Merus BV is MRUS

The IPO of Merus BV took place on 2016-05-19

Similar Industry Stocks (PHARMACEUTICAL PREPARATIONS)

Last Price
Chg
Chg%
$50.53
-0.48
-0.94%
$1.42
0.01
+0.71%
$12.81
-0.08
-0.62%
$0.42
-0
-0.45%
$4.58
0.2
+4.57%

Most Active

Last Price
Chg
Chg%
$58.63
-1.03
-1.73%
$92.12
-4.67
-4.82%
$5.12
-0.61
-10.65%
Apple Inc (AAPL)
$145.03
-5.62
-3.73%
$0.06
0.01
+12.74%

Top Gainers

Last Price
Chg
Chg%
$73
42.7
+140.92%
Oi S.A (OIBR-C)
$0
0
+100%
$0.02
0.01
+100%
$0.25
0.1
+66.44%
$2.85
1.01
+54.86%

Top Losers

Last Price
Chg
Chg%
$5.36
-22.58
-80.82%
$0.02
-0.06
-78.67%
Air T, Inc (AIRTW)
$0.01
-0.03
-75%
$4.51
-5.17
-53.41%
$11.5
-12.2
-51.48%

About

Merus NV, a clinical-stage immuno-oncology company, is dedicated to the discovery and development of bispecific antibody therapies in the Netherlands. The company is headquartered in Utrecht, the Netherlands.

Address

YALELAAN 62, 3584 CM UTRECHT, NL